Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

NIH Funds Study of Fully Personalized Immunotherapy AGS-004 Combined With a Latency Reversing Therapy for the Treatment of HIV

​ NIH Funds Study of Fully Personalized Immunotherapy AGS-004 Combined With a Latency Reversing Therapy for the Treatment of HIVApril 1, 2015 – (Argos) – Argos Therapeutics, Inc. (Nasdaq:ARGS), today announced that the NIH Division of AIDS has app ...[Read More]
Published: Apr-01-15
Tags: Science and Industry News

​ Douglas Lowy Named Acting Director of the National Cancer Institute

​ Douglas Lowy Named Acting Director of the National Cancer InstituteApril 1, 2015 – (NCI) – Douglas Lowy, M.D., today was officially named the National Cancer Institute’s (NCI) Acting Director. NCI is one of the 27 Institutes and Centers that com ...[Read More]
Published: Apr-01-15
Tags: Science and Industry News

Researchers Identify 'Bridge' State Necessary for Cellular Reprogramming

​ Researchers Identify 'Bridge' State Necessary for Cellular ReprogrammingApril 1, 2015 – (Stanford Medical) – The discovery that fully mature cells can be reprogrammed to what are known as induced pluripotent stem cells by exposure to just a few ...[Read More]
Published: Apr-01-15
Tags: Science and Industry News

Mini Enzyme Moves Gene Editing Closer to the Clinic

​ Mini Enzyme Moves Gene Editing Closer to the ClinicApril 1, 2015 – (Nature) – A tweak to a technique that edits DNA with pinpoint precision has boosted its ability to correct defective genes in people.   ...[Read More]
Published: Apr-01-15
Tags: Science and Industry News

Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue

​ Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue April 1, 2015 – (Organovo) – Organovo Holdings, Inc. (NYSE MKT: ONVO), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, presen ...[Read More]
Published: Apr-01-15
Tags: Science and Industry News

Intrexon Signs Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI)

​ Intrexon Signs Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI)April 1, 2015 – (Intrexon) – Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that Intrexon has signed ...[Read More]
Published: Apr-01-15
Tags: Science and Industry News

Ocata Therapeutics Successfully Completes Dosing in Phase 1/2 RPE Studies

​ Ocata Therapeutics Successfully Completes Dosing in Phase 1/2 RPE StudiesMarch 31, 2015 – (Ocata) – Ocata Therapeutics, Inc. (NASDAQ:OCAT), a leader in the field of regenerative ophthalmology, today announced that the company has completed dosin ...[Read More]
Published: Mar-31-15
Tags: Science and Industry News

​China Mulls Rules for Stem-Cell Research

​China Mulls Rules for Stem-Cell ResearchMarch 30, 2015 – (Xinhua) – China is soliciting public review of a set of new rules on stem-cell research. ...[Read More]
Published: Mar-30-15
Tags: Science and Industry News

Prototype 'Nanoneedles' Generate New Blood Vessels in Mice

​ Prototype 'Nanoneedles' Generate New Blood Vessels in MiceMarch 30, 2015 – (Imperial College London) – The researchers, from Imperial College London and Houston Methodist Research Institute in the USA, hope their nanoneedle technique could ultim ...[Read More]
Published: Mar-30-15
Tags: Science and Industry News

Texas Heart Institute Halfway to Goal of Recruiting Patients With Peripheral Artery Disease for Adult Stem Cell Trial

​ Texas Heart Institute Halfway to Goal of Recruiting Patients With Peripheral Artery Disease for Adult Stem Cell Trial March 30, 2015 – (Texas Heart Institute) – Doctors and researchers at the Texas Heart Institute (THI) are halfway to their goal ...[Read More]
Published: Mar-30-15
Tags: Science and Industry News
 Next >>